Mucopolysaccharidoses clinical trials
The registry lists 59 studies for Mucopolysaccharidoses across more than 10 countries. 11 are recruiting or about to start. 25 of them are mainly about Mucopolysaccharidoses (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-21. Counting its 5 narrower conditions too, such as Mucopolysaccharidosis IV: 308 studies, 53 open.
Get an email when these change. Save the Mucopolysaccharidoses studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Shire (5) · Patricia I. Dickson, M.D. (3) · Assiut University (3) · Ultragenyx Pharmaceutical Inc (3) · Alexion Pharmaceuticals, Inc. (3) · Takeda (2) · University of Minnesota (2) · Children's Hospital of Orange County (2)
What is being tested here
Drugs under test in Mucopolysaccharidoses studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The study
- Nov 2026Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT · Paul Szabolcs
Who these studies take
Of the 6 Mucopolysaccharidoses studies recruiting now, 2 (33%) set no upper age limit and 3 (50%) stop at 75 or younger. 5 (83%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 2 (33%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 4 (67%) | 4 (67%) |
| 18 | 5 (83%) | 5 (83%) |
| 30 | 5 (83%) | 5 (83%) |
| 40 | 5 (83%) | 5 (83%) |
| 50 | 5 (83%) | 5 (83%) |
| 65 | 3 (50%) | 3 (50%) |
| 75 | 3 (50%) | 3 (50%) |
| 85 | 3 (50%) | 3 (50%) |
Across all 59 studies, recruiting or not: 59% stop at 75 or younger and 59% at 65; 92% take children; 2% are for women only and 10% for men only; 14% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 50 of 59. Browse all 59 → or search them.
- Cardiac Structure and Function in MPSRecruitingNCT073615361 country
- A Phase I/II Trial of JR-446 in Mucopolysaccharidosis Type IIIB (MPS IIIB)RecruitingNCT07640984Phase 1/23 countries
- Single Injection of rAAV9-CMV-hNAGLUop Gene for Patients With Mucopolysaccharidosis (MPS) IIIBNot yet recruitingNCT07818759Phase 1/21 country
- Physical Activity Intervention for MPSRecruitingNCT074491431 country
- Natural History to Assess Disease in Patients With MPS IIICNot yet recruitingNCT077120031 country
- Morphology in Oral Rare Syndromes & Artificial Intelligence for Clinical DiagnosisNot yet recruitingNCT07666269Not applicable1 country
- Registry of Patients Diagnosed With Lysosomal Storage DiseasesRecruitingNCT056199001 country
- Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCTRecruitingNCT01962415Phase 21 country
- The Myelin Disorders Biorepository ProjectRecruitingNCT030473691 country
- Pediatric Arthropathy Beyond Inflammation: Clinical Spectrum and Diagnostic Approach at Assiut University Children HospitalNot yet recruitingNCT07173010
- Nutritional Assessment in Patient of Mucopolysaccharide "Not yet recruitingNCT07136896Not applicable
- Cardiovascular Structure and Function in the MucopolysaccharidosesActive, not recruitingNCT050634351 country
- A Study to Investigate the Efficacy and Safety of OTL-203 in Subjects With MPS-IH Compared With Standard of Care With Allogeneic HSCTActive, not recruitingNCT06149403Phase 34 countries
- A Study of ELAPRASE in Treatment-naïve Participants With Hunter Syndrome (Mucopolysaccharidosis [MPS] II)WithdrawnNCT05494593Phase 41 country
- LeukoSEQ: Whole Genome Sequencing as a First-Line Diagnostic Tool for LeukodystrophiesCompletedNCT026991901 country
- A Natural History Study of Sanfilippo Syndrome Type DCompletedNCT056488511 country
- Longitudinal Study of Bone Disease in Children with Mucopolysaccharidoses (MPS) I, II, and VICompletedNCT015214291 country
- A Study of the Tolerance, Safety, and Pharmacokinetics of GNR-055 in Healthy VolunteersCompletedNCT06475404Phase 11 country
- Safety Study of Gene Modified Donor T Cell Infusion After Stem Cell Transplant for Non-Malignant DiseasesTerminatedNCT02231710Phase 11 country
- Validation and Reliability of Iris Cameras in MucopolysaccharidosesStatus unknownNCT053542191 country
- Evaluation of Losartan on Cardiovascular Disease in Patients With Mucopolysaccharidoses IV A and VIStatus unknownNCT03632213Phase 21 country
- A Study to Improve the Awareness of Mucopolysaccharidosis Type II in BrazilCompletedNCT051554881 country
- Respiratory Cathepsins, Proteases Inhibitors and Glycosaminoglycans (GAG) in MucopolysaccharidosisCompletedNCT041126021 country
- Natural History Study of Patients With MPS IIIACompletedNCT027463415 countries
- The Effect of Enzyme Replacement Therapy in MucopolysaccharidosisCompletedNCT05006222Not applicable1 country
- A Safety and Dose Ranging Study of Idursulfase (Intrathecal) Administration Via an Intrathecal Drug Delivery Device in Pediatric Patients With Hunter Syndrome Who Have Central Nervous System Involvement and Are Receiving Treatment With Elaprase®CompletedNCT00920647Phase 1/22 countries
- Safety, Tolerability, Ascending Dose and Dose Frequency Study of rhHNS Via an IDDD in MPS IIIA PatientsCompletedNCT01155778Phase 1/22 countries
- An Extension Study to Determine Safety and Efficacy for Pediatric Patients With MPS Type IIIA Disease Who Participated in Study HGT-SAN-093.TerminatedNCT02350816Phase 27 countries
- Observational Study to Evaluate Neurodevelopmental Status in Pediatric Patients With Hunter Syndrome (MPS II)CompletedNCT018221845 countries
- Mucopolysaccharidosis (MPS) I, II, and VI Screening in a High-Risk Population With Previous Surgical Repair or Presence of Inguinal and/or Umbilical Hernia in Combination With Pediatric ENT Surgery (The HATT Project)TerminatedNCT020950157 countries
- Carotid Structure and Function in MPS Syndromes: A Multicenter Study of the Lysosomal Disease NetworkCompletedNCT015868711 country
- Pregnancy With Morquio Syndrome - What Are Patients' Perspectives and Has ERT Changed Them?CompletedNCT031500691 country
- Evaluation of Cardiac Affections in Patients With Mucopolysaccharidosis (MPS) in Assuit University Children Hospital (AUCH)Status unknownNCT04637646
- A Multi-cohort Study of the Tolerance, Safety, and Pharmacokinetics of GNR-055 in Healthy VolunteersCompletedNCT04539340Phase 11 country
- A Phase 3 Study of UX003 Recombinant Human Betaglucuronidase (rhGUS) Enzyme Replacement Therapy in Patients With Mucopolysaccharidosis Type 7 (MPS 7)CompletedNCT02230566Phase 31 country
- A Study of UX003 Recombinant Human Beta-Glucuronidase (rhGUS) Enzyme Replacement Therapy in Subjects With Mucopolysaccharidosis Type 7, Sly Syndrome (MPS 7)CompletedNCT02432144Phase 34 countries
- Assessment of Factors That Affected Respiratory Parameters in Mucopolysaccharidoses PatientsCompletedNCT044917471 country
- Study of UX003 Recombinant Human Beta-Glucuronidase (rhGUS) Enzyme Replacement Treatment in Mucopolysaccharidosis Type 7, Sly Syndrome (MPS 7) Patients Less Than 5 Years of AgeCompletedNCT02418455Phase 23 countries
- Lysosomal Storage Disease: Health, Development, and Functional Outcome Surveillance in Preschool ChildrenCompletedNCT019380141 country
- Longitudinal Studies of Brain Structure and Function in MPS DisordersCompletedNCT018703752 countries
- Natural History Study to Characterise the Course of Disease Progression in Participants With Mucopolysaccharidosis Type IIIBTerminatedNCT022934086 countries
- Safety, Pharmacokinetics, and Pharmacodynamics/Efficacy of SBC-103 in Mucopolysaccharidosis III, Type B (MPS IIIB)CompletedNCT02324049Phase 1/23 countries
- Allogeneic Bone Marrow Transplant for Inherited Metabolic DisordersCompletedNCT01043640Phase 21 country
- A Cross-specialty Collaboration Platform for Mucopolysaccharidosis Confirmative DiagnosisStatus unknownNCT03017677
- New Imaging Technology to Assess Effect of Enzyme Replacment Therapy on Eye Disease Progession in MucopolysacchardiosisStatus unknownNCT025831521 country
- Effects of Adalimumab in Mucopolysaccharidosis Types I, II and VICompletedNCT02437253Phase 1/21 country
- Dynamic Gait Analysis in Children With Mucopolysaccharidosis Type IVaWithdrawnNCT021532551 country
- Evaluation of Blood Brain Barrier Integrity and Structural Abnormalities in MPS IIIB Patients Using Multimodal Magnetic Resonance ImagingCompletedNCT020901791 country
- A Study of Intrathecal Enzyme Therapy for Cognitive Decline in MPS ICompletedNCT00852358Not applicable1 country
- Natural History Studies of Mucopolysaccharidosis IIICompletedNCT020378801 country